Neurobiological Mechanisms of Placebo Responses

Expectations, positive or negative, are modulating factors influencing behavior. They are also thought to underlie placebo effects, potentially impacting perceptions and biological processes. We used sustained pain as a model to determine the neural mechanisms underlying placebo‐induced analgesia an...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2009-03, Vol.1156 (1), p.198-210
Main Authors: Zubieta, Jon-Kar, Stohler, Christian S.
Format: Article
Language:English
Subjects:
Analgesia - psychology
Brain Mapping
Dopamine - metabolism
human
Humans
Models, Biological
Nerve Net - physiology
Nervous System Physiological Phenomena - physiology
opioid dopamine
Opioid Peptides - metabolism
Opioid Peptides - pharmacology
pain
placebo
Placebo Effect
Placebos
positron emission tomography (PET)
stress
Synaptic Transmission - drug effects
Synaptic Transmission - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Expectations, positive or negative, are modulating factors influencing behavior. They are also thought to underlie placebo effects, potentially impacting perceptions and biological processes. We used sustained pain as a model to determine the neural mechanisms underlying placebo‐induced analgesia and affective changes in healthy humans. Subjects were informed that they could receive either an active agent or an inactive compound, similar to routine clinical trials. Using PET and the μ‐opioid selective radiotracer [11C]carfentanil we demonstrate placebo‐induced activation of opioid neurotransmission in a number of brain regions. These include the rostral anterior cingulate, orbitofrontal and dorsolateral prefrontal cortex, anterior and posterior insula, nucleus accumbens, amygdala, thalamus, hypothalamus, and periaqueductal grey. Some of these regions overlap with those involved in pain and affective regulation but also motivated behavior. The activation of endogenous opioid neurotransmission was further associated with reductions in pain report and negative affective state. Additional studies with the radiotracer [11C]raclopride, studies labeling dopamine D2/3 receptors, also demonstrate the activation of nucleus accumbens dopamine during placebo administration under expectation of analgesia. Both dopamine and opioid neurotransmission were related to expectations of analgesia and deviations from those initial expectations. When the activity of the nucleus accumbens was probed with fMRI using a monetary reward expectation paradigm, its activation was correlated with both dopamine, opioid responses to placebo in this region and the formation of placebo analgesia. These data confirm that specific neural circuits and neurotransmitter systems respond to the expectation of benefit during placebo administration, inducing measurable physiological changes.
ISSN:0077-8923
1749-6632
1930-6547
DOI:10.1111/j.1749-6632.2009.04424.x